PVLA
PVLA
US6979471090
Palvella Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
38.602.000 14.095.000
173.9%
Operating Income -38.602.000 -14.095.000
173.9%
Pretax Income -41.715.000 -17.434.000
139.3%
Net Income Common Stockholders -41.715.000 -17.434.000
139.3%
-- --
--
-- --
--
ende